Vetera Gold (Canada)

Manufacturer: Boehringer

Encephalomyelitis-rhinopneumonitis-influenza-west Nile Virus Vaccine,

Eastern & Western, Killed Virus

Tetanus Toxoid

Veterinary Use Only

Vetera Gold Indications

For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by Eastern and Western Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; as an aid in the reduction of respiratory disease caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4), and Equine Influenza virus types A2 North American and A2 Eurasian. The duration of immunity against Equine Influenza is at least

6 months, and against West Nile Virus is at least 12 months.

Administration And Dosage

Shake well before use. Using aseptic technique, vaccinate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure

with a single 1 mL intramuscular dose.

Precautions

Store at 2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Preservatives: Gentamicin and Amphotericin B.

Manufactured By: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.s.a.

U.s. Vet. Lic. No. 124

Manufactured For: Boehringer Ingelheim (canada) Ltd., Burlington, Ontario L7l 5h4

1 Dose/1 mL	36210-00
10 Doses/10 mL	36209-00

Nac No.

12301260